Drugs / angiopoietin 1
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06364150 Background | Jul 2024 → May 2025 overdue | acute myocardial infarction | Seoul National Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | angiopoietin 1 | “mobPBSC will be primed with angiopoietin 1 (Ang1) for 1 hour.” NCT06364150 ↗ |
| Known as | Ang1 | “mobPBSC will be primed with angiopoietin 1 (Ang1) for 1 hour.” NCT06364150 ↗ |